ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yabo Zhou
Matched on ORCID iD 0000-0002-0519-2158; OpenAlex author ID A5057172127, A5124337972. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP. Co-author DOI 10.1038/s41423-026-01390-2↗
- Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. Co-author DOI 10.1038/s41556-022-00857-4↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bo Huang · 2 shared papers, 2022–2026 · strength 0.36
- Paper Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA… DOI 10.1038/s41423-026-01390-2↗
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4↗
- Jiadi Lv · 2 shared papers, 2022–2026 · strength 0.36
- Paper Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA… DOI 10.1038/s41423-026-01390-2↗
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4↗
- Heng Zhang · 1 shared paper, 2026 · strength 0.23
- Zi Wang · 1 shared paper, 2026 · strength 0.23
- Yuying Liu · 1 shared paper, 2022 · strength 0.13
- Wei‐Min Tong · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.